Aspects of eukaryotic-like signaling in Gram-positive cocci: A focus on virulence

Future Microbiology

Volumn 6, Issue 7, 2011, Pages 747-761

  Burnside, Kellie ^a   Rajagopal, Lakshmi ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

antibiotic resistance; Enterococcus faecalis; serine threonine kinase; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus mutans; Streptococcus pneumoniae; Streptococcus pyogenes; virulence

Indexed keywords

CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; ERTAPENEM; NAFCILLIN; PROTEIN SERINE THREONINE KINASE;

ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIAL VIRULENCE; BIOSYNTHESIS; CELL STRUCTURE; DRUG TARGETING; ENTEROCOCCUS FAECALIS; ENZYME PHOSPHORYLATION; GRAM POSITIVE COCCI; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE COCCI; HUMANS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; EUKARYOTA; POSIBACTERIA; PROKARYOTA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 79961038710     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.62     Document Type: Review

References (151)

1. Krishna RG, Wold F. Posttranslational modifications. In: Protein Analysis and Design. Angeletti RH (Ed.). Academic Press, CA, USA 121-206 (1998).
2. Raggiaschi R, Gotta S, Terstappen GC. Phosphoproteome analysis. Biosci. Rep. 25(1-2), 33-44 (2005). (Pubitemid 41437708)
3. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241(4861), 42-52 (1988).
4. Shi L, Potts M, Kennelly PJ. The serine, threonine, and/or tyrosine-specific protein kinases and protein phosphatases of prokaryotic organisms: a family portrait. FEMS Microbiol. Rev. 22(4), 229-253 (1998). (Pubitemid 28557044)
5. Foussard M, Cabantous S, Pedelacq J et al. The molecular puzzle of two-component signaling cascades. Microbes Infect. 3(5), 417-424 (2001). (Pubitemid 32441665)
6. Two-component Signal Transduction. Hoch J, Silhavy T (Eds). American Society for Microbiology, Washington, DC, USA (1995).
7. Stock AM, Robinson VL, Goudreau PN. Two-component signal transduction. Annu. Rev. Biochem. 69, 183-215 (2000).
8. Munoz-Dorado J, Inouye S, Inouye M. A gene encoding a protein serine/threonine kinase is required for normal development of M. xanthus, a Gram-negative bacterium. Cell 67(5), 995-1006 (1991). (Pubitemid 121001513)
9. Hanlon WA, Inouye M, Inouye S. Pkn9, a ser/thr protein kinase involved in the development of Myxococcus xanthus. Mol. Microbiol. 23(3), 459-471 (1997). (Pubitemid 27051376)
10. Inouye S, Jain R, Ueki T et al. A large family of eukaryotic-like protein Ser/Thr kinases of Myxococcus xanthus, a developmental bacterium. Microb. Comp. Genomics 5(2), 103-120 (2000).
11. Matsumoto A, Hong SK, Ishizuka H, Horinouchi S. Phosphorylation of the AfsR protein involved in secondary metabolism in Streptomyces species by a eukaryotic-type protein kinase. Gene 146(1), 47-56 (1994).
12. Ogawara H, Aoyagi N, Watanabe M, Urabe H. Sequences and evolutionary analyses of eukaryotic-type protein kinases from Streptomyces coelicolor A3(2). Microbiology 145, 3343-3352 (1999). (Pubitemid 30018779)
13. Zhang CC. A gene encoding a protein related to eukaryotic protein kinases from the filamentous heterocystous cyanobacterium Anabaena PCC 7120. Proc. Natl Acad. Sci. USA 90(24), 11840-11844 (1993).
14. Zhang CC, Friry A, Peng L. Molecular and genetic analysis of two closely linked genes that encode, respectively, a protein phosphatase 1/2A/2B homolog and a protein kinase homolog in the cyanobacterium Anabaena sp. strain PCC7120. J. Bacteriol. 180(10), 2616-2622 (1998). (Pubitemid 28213258)
15. Zhang CC, Gonzalez L, Phalip V. Survey, analysis and genetic organization of genes encoding eukaryotic-like signaling proteins on a cyanobacterial genome. Nucleic Acids Res. 26(16), 3619-3625 (1998). (Pubitemid 28367964)
16. Madec E, Laszkiewicz A, Iwanicki A, Obuchowski M, Seror S. Characterization of a membrane-linked Ser/Thr protein kinase in Bacillus subtilis, implicated in developmental processes. Mol. Microbiol. 46(2), 571-586 (2002). (Pubitemid 35340965)
17. Shakir SM, Bryant KM, Larabee JL et al. Regulatory interactions of a virulence-associated serine/threonine phosphatase-kinase pair in Bacillus anthracis. J. Bacteriol. 192(2), 400-409 (2010).
18. Rajagopal L, Clancy A, Rubens CE. A eukaryotic type serine/threonine kinase and phosphatase in Streptococcus agalactiae reversibly phosphorylate an inorganic pyrophosphatase and affect growth, cell segregation, and virulence. J. Biol. Chem. 278(16), 14429-14441 (2003). (Pubitemid 36799996)
19. Hussain H, Branny P, Allan E. A eukaryotic-type serine/threonine protein kinase is required for biofilm formation, genetic competence, and acid resistance in Streptococcus mutans. J. Bacteriol. 188(4), 1628-1632 (2006). (Pubitemid 43228697)
20. Echenique J, Kadioglu A, Romao S, Andrew PW, Trombe MC. Protein serine/threonine kinase StkP positively controls virulence and competence in Streptococcus pneumoniae. Infect. Immun. 72(4), 2434-2437 (2004). (Pubitemid 38419967)
21. Jin H, Pancholi V. Identification and biochemical characterization of a eukaryotic-type serine/threonine kinase and its cognate phosphatase in Streptococcus pyogenes: their biological functions and substrate identification. J. Mol. Biol. 357(5), 1351-1372 (2006).
22. Av-Gay Y, Davies J. Components of eukaryotic-like protein signaling pathways in Mycobacterium tuberculosis. Microb. Comp. Genomics 2, 63-73 (1997).
23. Av-Gay Y, Everett M. The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends Microbiol. 8(5), 238-244 (2000). (Pubitemid 30236245)
24. Chaba R, Raje M, Chakraborti PK. Evidence that a eukaryotic-type serine/threonine protein kinase from Mycobacterium tuberculosis regulates morphological changes associated with cell division. Eur. J. Biochem. 269(4), 1078-1085 (2002). (Pubitemid 34175366)
25. Galyov EE, Hakansson S, Forsberg A, Wolf-Watz H. A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 361(6414), 730-732 (1993). (Pubitemid 23070481)
26. Hakansson S, Galyov EE, Rosqvist R, Wolf-Watz H. The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol. Microbiol. 20(3), 593-603 (1996). (Pubitemid 26151900)
27. Archambaud C, Gouin E, Pizarro-Cerda J, Cossart P, Dussurget O. Translation elongation factor EF-Tu is a target for Stp, a serine-threonine phosphatase involved in virulence of Listeria monocytogenes. Mol. Microbiol. 56(2), 383-396 (2005). (Pubitemid 40516779)
28. Lima A, Duran R, Schujman GE et al. Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches. J. Proteomics DOI:10.1016/j.jprot.2011.03.005 (2011) (Epub ahead of print).
29. Wang J, Li C, Yang H, Mushegian A, Jin S. A novel serine/threonine protein kinase homologue of Pseudomonas aeruginosa is specifically inducible within the host infection site and is required for full virulence in neutropenic mice. J. Bacteriol. 180(24), 6764-6768 (1998). (Pubitemid 29006098)
30. Kristich CJ, Wells CL, Dunny GM. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc. Natl Acad. Sci. USA 104(9), 3508-3513 (2007). (Pubitemid 46364189)
31. Beltramini AM, Mukhopadhyay CD, Pancholi V. Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect. Immun. 77(4), 1406-1416 (2009).
32. Truong-Bolduc QC, Ding Y, Hooper DC. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. J. Bacteriol. 190(22), 7375-7381 (2008).
33. De Lencastre H, Wu SW, Pinho MG et al. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb. Drug Resist. 5(3), 163-175 (1999). (Pubitemid 29519892)
34. Bogoyevitch MA, Barr RK, Ketterman AJ. Peptide inhibitors of protein kinases-discovery, characterisation and use. Biochim. Biophys. Acta 1754(1-2), 79-99 (2005). (Pubitemid 41797689)
35. Cheng H, Force T. Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ. Res. 106(1), 21-34 (2010).
36. Sachsenmaier C. Targeting protein kinases for tumor therapy. Onkologie 24(4), 346-355 (2001). (Pubitemid 34701519)
37. Cohen P. Classification of protein-serine/threonine phosphatases: identification and quantitation in cell extracts. Methods Enzymol. 201, 389-398 (1991).
38. McConnell JL, Wadzinski BE. Targeting protein serine/threonine phosphatases for drug development. Mol. Pharmacol. 75(6), 1249-1261 (2009).
39. Lu J, Kovach JS, Johnson F et al. Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms. Proc. Natl Acad. Sci. USA 106(28), 11697-11702 (2009).
40. Ventura JJ, Nebreda AR. Protein kinases and phosphatases as therapeutic targets in cancer. Clin. Transl. Oncol. 8(3), 153-160 (2006).
41. Jones G, Dyson P. Evolution of transmembrane protein kinases implicated in coordinating remodeling of Gram-positive peptidoglycan: inside versus outside. J. Bacteriol. 188(21), 7470-7476 (2006). (Pubitemid 44646246)
42. Yeats C, Finn RD, Bateman A. The PASTA domain: a b-lactam-binding domain. Trends Biochem. Sci. 27(9), 438-440 (2002).
43. Shah IM, Laaberki MH, Popham DL, Dworkin J. A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to peptidoglycan fragments. Cell 135(3), 486-496 (2008).
44. Bork P, Brown NP, Hegyi H, Schultz J. The protein phosphatase 2C (PP2C) superfamily: detection of bacterial homologues. Protein Sci. 5, 1421-1425 (1996). (Pubitemid 26239449)
45. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell 139(3), 468-484 (2009).
46. Rantanen MK, Lehtio L, Rajagopal L, Rubens CE, Goldman A. Structure of the Streptococcus agalactiae family II inorganic pyrophosphatase at 2.80 A resolution. Acta Crystallogr. D. Biol. Crystallogr. 63(Pt 6), 738-743 (2007). (Pubitemid 46787699)
47. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet. Gynecol. 96(4), 498-503 (2000).
48. Mullaney DM. Group B streptococcal infections in newborns. J. Obstet. Gynecol. Neonatal Nurs. 30(6), 649-658 (2001).
49. Baker CJ, Edwards MW. Group B streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant. Remington JS, Klein JO (Eds). WB Saunders, PA, USA 980-1054 (1995).
50. Baker CJ, Edwards MS. Group B streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant. Remington JS, Klein JO (Eds). WB Saunders, PA, USA 1091-1156 (2001).
51. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41(6), 839-847 (2005). (Pubitemid 41266752)
52. Farley MM. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33(4), 556-561 (2001). (Pubitemid 32709591)
53. Blumberg HM, Stephens DS, Modansky M et al. Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173(2), 365-373 (1996). (Pubitemid 26042436)
54. Schrag SJ, Arnold KE, Mohle-Boetani JC et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet. Gynecol. 102(4), 753-760 (2003). (Pubitemid 37206411)
55. Rajagopal L, Vo A, Silvestroni A, Rubens CE. Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Mol. Microbiol. 56(5), 1329-1346 (2005). (Pubitemid 40756014)
56. Rajagopal L, Vo A, Silvestroni A, Rubens CE. Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Mol. Microbiol. 62(4), 941-957 (2006). (Pubitemid 44655310)
57. Lin WJ, Walthers D, Connelly JE et al. Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR. Mol. Microbiol. 71(6), 1477-1495 (2009).
58. Lembo A, Gurney MA, Burnside K et al. Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol. Microbiol. 77(2), 431-443 (2010).
59. Hensler ME, Liu GY, Sobczak S, Benirschke K, Nizet V, Heldt GP. Virulence role of group B Streptococcus b-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection. J. Infect. Dis. 191(8), 1287-1291 (2005).
60. Puliti M, Nizet V, von Hunolstein C et al. Severity of group B streptococcal arthritis is correlated with b-hemolysin expression. J. Infect. Dis. 182(3), 824-832 (2000).
61. Ring A, Braun JS, Nizet V, Stremmel W, Shenep JL. Group B streptococcal b-hemolysin induces nitric oxide production in murine macrophages. J. Infect. Dis. 182(1), 150-157 (2000). (Pubitemid 30497799)
62. Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M, Rubens CE. Group B streptococcal b-hemolysin expression is associated with injury of lung epithelial cells. Infect. Immun. 64(9), 3818-3826 (1996). (Pubitemid 26298710)
63. Nizet V, Gibson RL, Rubens CE. The role of group B streptococci b-hemolysin expression in newborn lung injury. Adv. Exp. Med. Biol. 418, 627-630 (1997). (Pubitemid 27438508)
64. Gibson RL, Nizet V, Rubens CE. Group B streptococcal b-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr. Res. 45(5 Pt 1), 626-634 (1999). (Pubitemid 29203591)
65. Doran KS, Chang JC, Benoit VM, Eckmann L, Nizet V. Group B streptococcal b-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J. Infect. Dis. 185(2), 196-203 (2002). (Pubitemid 34056443)
66. Nizet V. Streptococcal b-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol. 10(12), 575-580 (2002). (Pubitemid 36139879)
67. Doran KS, Liu GY, Nizet V. Group B streptococcal b-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J. Clin. Invest. 112(5), 736-744 (2003). (Pubitemid 38057714)
68. Ring A, Braun JS, Pohl J, Nizet V, Stremmel W, Shenep JL. Group B streptococcal b-hemolysin induces mortality and liver injury in experimental sepsis. J. Infect. Dis. 185(12), 1745-1753 (2002). (Pubitemid 34615468)
69. Lamy MC, Zouine M, Fert J et al. CovS/CovR of group B Streptococcus: a two-component global regulatory system involved in virulence. Mol. Microbiol. 54(5), 1250-1268 (2004). (Pubitemid 39578269)
70. Jiang SM, Cieslewicz MJ, Kasper DL, Wessels MR. Regulation of virulence by a two-component system in group B streptococcus. J. Bacteriol. 187(3), 1105-1113 (2005). (Pubitemid 40189783)
71. Jiang SM, Ishmael N, Hotopp JD et al. Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J. Bacteriol. 190(6), 1956-1965 (2008). (Pubitemid 351355318)
72. Ulijasz AT, Falk SP, Weisblum B. Phosphorylation of the RitR DNA-binding domain by a Ser-Thr phosphokinase: implications for global gene regulation in the streptococci. Mol. Microbiol. 71(2), 382-390 (2009).
73. Chao JD, Papavinasasundaram KG, Zheng X et al. Convergence of Ser/Th and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis. J. Biol. Chem. 285(38), 29239-29246 (2010).
74. Silvestroni A, Jewell KA, Lin WJ et al. Identification of serine/threonine kinase substrates in the human pathogen group B Streptococcus. J. Proteome Res. 8(5), 2563-2574 (2009).
75. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317(3), 146-149 (1987). (Pubitemid 17092152)
76. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of Group A streptococcal diseases. Lancet Infect. Dis. 5(11), 685-694 (2005). (Pubitemid 41505357)
77. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of Group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166(2), 374-382 (1992).
78. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. Dis. 1(3), 69-78 (1995).
79. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA. Streptococcal M protein: a-helical coiled-coil structure and arrangement on the cell surface. Proc. Natl Acad. Sci. USA 78(8), 4689-4693 (1981). (Pubitemid 12225545)
80. Pancholi V, Boel G, Jin H. Streptococcus pyogenes Ser/Thr kinase-regulated cell wall hydrolase is a cell division plane-recognizing and chain-forming virulence factor. J. Biol. Chem. 285(40), 30861-30874 (2010).
81. Dorman CJ, Deighan P. Regulation of gene expression by histone-like proteins in bacteria. Curr. Opin. Genet. Dev. 13(2), 179-184 (2003). (Pubitemid 36369742)
82. Rimsky S. Structure of the histone-like protein H-NS and its role in regulation and genome superstructure. Curr. Opin. Microbiol. 7(2), 109-114 (2004). (Pubitemid 38447041)
83. Peterson CL, Laniel MA. Histones and histone modifications. Curr. Biol. 14(14), R546-R551 (2004).
84. Aki T, Choy HE, Adhya S. Histone-like protein HU as a specific transcriptional regulator: co-factor role in repression of gal transcription by GAL repressor. Genes Cells 1(2), 179-188 (1996). (Pubitemid 126673116)
85. Cerutti H, Casas-Mollano JA. Histone H3 phosphorylation: universal code or lineage specific dialects? Epigenetics 4(2), 71-75 (2009).
86. Burnside K, Lembo A, de Los Reyes M et al. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS ONE 5(6), E11071 (2010).
87. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin. Respir. Crit. Care Med. 30(2), 189-209 (2009).
88. Novakova L, Saskova L, Pallova P et al. Characterization of a eukaryotic type serine/threonine protein kinase and protein phosphatase of Streptococcus pneumoniae and identification of kinase substrates. FEBS J. 272(5), 1243-1254 (2005). (Pubitemid 40314942)
89. Saskova L, Novakova L, Basler M, Branny P. Eukaryotic-type serine/threonine protein kinase StkP is a global regulator of gene expression in Streptococcus pneumoniae. J. Bacteriol. 189(11), 4168-4179 (2007). (Pubitemid 46847365)
90. Oggioni MR, Trappetti C, Kadioglu A et al. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol. Microbiol. 61(5), 1196-1210 (2006). (Pubitemid 44215421)
91. Giefing C, Jelencsics KE, Gelbmann D, Senn BM, Nagy E. The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro. Microbiology 156(Pt 6), 1697-1707 (2010).
92. Giefing C, Meinke AL, Hanner M et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205(1), 117-131 (2008). (Pubitemid 351185720)
93. Dias R, Felix D, Canica M, Trombe MC. The highly conserved serine threonine kinase StkP of Streptococcus pneumoniae contributes to penicillin susceptibility independently from genes encoding penicillin-binding proteins. BMC Microbiol. 9, 121 (2009).
94. Osaki M, Arcondeguy T, Bastide A, Touriol C, Prats H, Trombe MC. The StkP/PhpP signaling couple in Streptococcus pneumoniae: cellular organization and physiological characterization. J. Bacteriol. 191(15), 4943-4950 (2009).
95. Johnsborg O, Havarstein LS. Regulation of natural genetic transformation and acquisition of transforming DNA in Streptococcus pneumoniae. FEMS Microbiol. Rev. 33(3), 627-642 (2009).
96. Ulijasz AT, Andes DR, Glasner JD, Weisblum B. Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator. J. Bacteriol. 186(23), 8123-8136 (2004). (Pubitemid 39552525)
97. Throup JP, Koretke KK, Bryant AP et al. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol. Microbiol. 35(3), 566-576 (2000). (Pubitemid 30085274)
98. Busby S, Ebright RH. Transcription activation by catabolite activator protein (CAP). J. Mol. Biol. 293(2), 199-213 (1999). (Pubitemid 29516164)
99. Mengin-Lecreulx D, van Heijenoort J. Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli. J. Biol. Chem. 271(1), 32-39 (1996). (Pubitemid 26027279)
100. Jolly L, Ferrari P, Blanot D, Van Heijenoort J, Fassy F, Mengin-Lecreulx D. Reaction mechanism of phosphoglucosamine mutase from Escherichia coli. Eur. J. Biochem. 262(1), 202-210 (1999). (Pubitemid 29242627)
101. Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol. Rev. 44(2), 331-384 (1980). (Pubitemid 11128312)
102. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50(4), 353-380 (1986). (Pubitemid 17202894)
103. Sansone C, Van Houte J, Joshipura K, Kent R, Margolis HC. The association of mutans streptococci and non-mutans streptococci capable of acidogenesis at a low pH with dental caries on enamel and root surfaces. J. Dent. Res. 72(2), 508-516 (1993).
104. Kuramitsu HK. Virulence factors of mutans streptococci: role of molecular genetics. Crit. Rev. Oral Biol. Med. 4(2), 159-176 (1993). (Pubitemid 23103290)
105. Yamashita Y, Takehara T, Kuramitsu HK. Molecular characterization of a Streptococcus mutans mutant altered in environmental stress responses. J. Bacteriol. 175(19), 6220-6228 (1993). (Pubitemid 23292436)
106. Banu LD, Conrads G, Rehrauer H, Hussain H, Allan E, van der Ploeg JR. The Streptococcus mutans serine/threonine kinase, PknB, regulates competence development, bacteriocin production, and cell wall metabolism. Infect. Immun. 78(5), 2209-2220 (2010).
107. Zhu L, Kreth J. Role of Streptococcus mutans eukaryotic-type serine/threonine protein kinase in interspecies interactions with Streptococcus sanguinis. Arch. Oral Biol. 55(5), 385-390 (2010).
108. Poh CH, Oh HM, Tan AL. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital. J. Infect. 52(5), 383-386 (2006).
109. Rince A, Flahaut S, Auffray Y. Identification of general stress genes in Enterococcus faecalis. Int. J. Food Microbiol. 55(1-3), 87-91 (2000). (Pubitemid 30160810)
110. Rince A, Le Breton Y, Verneuil N, Giard JC, Hartke A, Auffray Y. Physiological and molecular aspects of bile salt response in Enterococcus faecalis. Int. J. Food Microbiol. 88(2-3), 207-213 (2003). (Pubitemid 37329497)
111. Sherman JM. The streptococci. Bacteriol. Rev. 1(1), 3-97 (1937).
112. Moellering RC Jr. Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14(6), 1173-1176 (1992).
113. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5(1), 9-17 (1999). (Pubitemid 29124770)
114. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5, 2 (2006).
115. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7(2), 178-182 (2001). (Pubitemid 32374323)
116. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144(5), 309-317 (2006). (Pubitemid 46768185)
117. Seybold U, Kourbatova EV, Johnson JG et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42(5), 647-656 (2006). (Pubitemid 43271378)
118. Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2), S114-S132 (2001). (Pubitemid 32424266)
119. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352(14), 1436-1444 (2005).
120. Noskin GA, Rubin RJ, Schentag JJ et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin. Infect. Dis. 45(9), 1132-1140 (2007). (Pubitemid 47580311)
121. Ohlsen K, Donat S. The impact of serine/threonine phosphorylation in Staphylococcus aureus. Int. J. Med. Microbiol. 300(2-3), 137-141 (2010).
122. Donat S, Streker K, Schirmeister T et al. Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. J. Bacteriol. 191(13), 4056-4069 (2009).
123. Debarbouille M, Dramsi S, Dussurget O et al. Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. J. Bacteriol. 191(13), 4070-4081 (2009).
124. Tamber S, Schwartzman J, Cheung AL. Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300. Infect. Immun. 78(8), 3637-3646 (2010).
125. Lomas-Lopez R, Paracuellos P, Riberty M, Cozzone AJ, Duclos B. Several enzymes of the central metabolism are phosphorylated in Staphylococcus aureus. FEMS Microbiol. Lett. 272(1), 35-42 (2007). (Pubitemid 46944461)
126. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205(2), 287-294 (2008). (Pubitemid 351281594)
127. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75(2), 1040-1044 (2007). (Pubitemid 46203470)
128. Kielian T, Cheung A, Hickey WF. Diminished virulence of an a-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect. Immun. 69(11), 6902-6911 (2001). (Pubitemid 32995450)
129. Hume EB, Dajcs JJ, Moreau JM, O'Callaghan RJ. Immunization with a-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect. Immun. 68(10), 6052-6055 (2000).
130. Nilsson IM, Hartford O, Foster T, Tarkowski A. a-toxin and g-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect. Immun. 67(3), 1045-1049 (1999). (Pubitemid 29108475)
131. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of a-toxin and protein A in pathogenesis. Infect. Immun. 62(6), 2478-2482 (1994). (Pubitemid 24157079)
132. Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and a-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55(12), 3103-3110 (1987). (Pubitemid 18008284)
133. DeLeo FR, Otto M. An antidote for Staphylococcus aureus pneumonia? J. Exp. Med. 205(2), 271-274 (2008). (Pubitemid 351281592)
134. Ragle BE, Bubeck Wardenburg J. Anti-a-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77(7), 2712-2718 (2009).
135. Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20(4), 214-220 (2004). (Pubitemid 38369193)
136. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15(2), 172-183 (2003). (Pubitemid 36332192)
137. Paterson GK, Blue CE, Mitchell TJ. Role of two-component systems in the virulence of Streptococcus pneumoniae. J. Med. Microbiol. 55(Pt 4), 355-363 (2006).
138. Hendriksen WT, Silva N, Bootsma HJ et al. Regulation of gene expression in Streptococcus pneumoniae by response regulator 09 is strain dependent. J. Bacteriol. 189(4), 1382-1389 (2007). (Pubitemid 46239759)
139. Cassat J, Dunman PM, Murphy E et al. Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 152(Pt 10), 3075-3090 (2006). (Pubitemid 44542387)
140. Miller M, Donat S, Rakette S et al. Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases. PLoS ONE 5(2), E9057 (2010).
141. Gaidenko TA, Kim TJ, Price CW. The PrpC serine-threonine phosphatase and PrkC kinase have opposing physiological roles in stationary-phase Bacillus subtilis cells. J. Bacteriol. 184(22), 6109-6114 (2002). (Pubitemid 35265890)
142. Obuchowski M, Madec E, Delattre D et al. Characterization of PrpC from Bacillus subtilis, a member of the PPM phosphatase family. J. Bacteriol. 182(19), 5634-5638 (2000).
143. Pietack N, Becher D, Schmidl SR et al. In vitro phosphorylation of key metabolic enzymes from Bacillus subtilis: PrkC phosphorylates enzymes from different branches of basic metabolism. J. Mol. Microbiol. Biotechnol. 18(3), 129-140 (2010).
144. Barthe P, Mukamolova GV, Roumestand C, Cohen-Gonsaud M. The structure of PknB extracellular PASTA domain from Mycobacterium tuberculosis suggests a ligand-dependent kinase activation. Structure 18(5), 606-615 (2010).
145. Fernandez P, Saint-Joanis B, Barilone N et al. The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth. J. Bacteriol. 188(22), 7778-7784 (2006). (Pubitemid 44764514)
146. Kang CM, Abbott DW, Park ST, Dascher CC, Cantley LC, Husson RN. The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Genes Dev. 19(14), 1692-1704 (2005). (Pubitemid 41058365)
147. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48(1), 77-84 (2003). (Pubitemid 36411469)
148. Ortiz-Lombardia M, Pompeo F, Boitel B, Alzari PM. Crystal structure of the catalytic domain of the PknB serine/threonine kinase from Mycobacterium tuberculosis. J. Biol. Chem. 278(15), 13094-13100 (2003). (Pubitemid 36800077)
149. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T. Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat. Struct. Biol. 10(3), 168-174 (2003). (Pubitemid 36297985)
150. Pereira SF, Goss L, Dworkin J. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol. Mol. Biol. Rev. 75(1), 192-212 (2011).
151. Greenstein AE, Grundner C, Echols N et al. Structure/function studies of Ser/Thr and Tyr protein phosphorylation in Mycobacterium tuberculosis. J. Mol. Microbiol. Biotechnol. 9(3-4), 167-181 (2005). (Pubitemid 43100078)